SOW
ACAD icon

State of Wyoming’s Acadia Pharmaceuticals ACAD Stock Holding History

State of Wyoming’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
48,794
+38,478
+373% +$847K 0.12% 90
2026
Q1 		$230K Sell
10,316
-7,496
-42% -$179K 0.03% 852
2025
Q4 		$476K Buy
17,812
+9,527
+115% +$228K 0.05% 392
2025
Q3 		$177K Buy
+8,285
New +$196K 0.02% 1039
2025
Q1 		– Sell
-10,406
Closed -$191K – 1623
2024
Q4 		$191K Buy
10,406
+4,315
+71% +$69.6K 0.02% 864
2024
Q3 		$93.7K Buy
+6,091
New +$102K 0.01% 1198
2024
Q1 		– Sell
-8,033
Closed -$252K – 1600
2023
Q4 		$252K Buy
8,033
+6,554
+443% +$157K 0.05% 405
2023
Q3 		$30.8K Sell
1,479
-3,146
-68% -$85.4K 0.01% 1408
2023
Q2 		$111K Buy
+4,625
New +$103K 0.03% 781
2023
Q1 		– Sell
-5,784
Closed -$92.1K – 1570
2022
Q4 		$92.1K Buy
+5,784
New +$90.4K 0.03% 815
2022
Q3 		– Sell
-5,550
Closed -$78K – 1493
2022
Q2 		$78K Sell
5,550
-6,967
-56% -$130K 0.05% 656
2022
Q1 		$304K Buy
12,517
+928
+8% +$22.5K 0.15% 83
2021
Q4 		$271K Buy
11,589
+2,071
+22% +$41.7K 0.13% 124
2021
Q3 		$158K Sell
9,518
-275
-3% -$5.3K 0.1% 239
2021
Q2 		$239K Buy
9,793
+8,139
+492% +$184K 0.15% 146
2021
Q1 		$43K Buy
+1,654
New +$72.8K 0.07% 237

Other funds holding ACAD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State of Wyoming's ACAD Position: Q2 2026 in Review

State of Wyoming increased its Acadia Pharmaceuticals (ACAD) stake by 373% in Q2 2026, buying an estimated $847K and bringing the position to 48,794 shares worth $1.23M. The position accounts for 0.12% of the portfolio, ranked #90.

State of Wyoming first reported a position in ACAD in Q1 2021 and has held it in 16 quarters since. 138 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • State of Wyoming held 48,794 shares of Acadia Pharmaceuticals worth $1.23M as of Q2 2026.
  • State of Wyoming bought 38,478 Acadia Pharmaceuticals shares in Q2 2026, an estimated $847K.
  • Acadia Pharmaceuticals made up 0.12% of State of Wyoming's portfolio in Q2 2026, its #90 holding.
  • State of Wyoming first reported a position in Acadia Pharmaceuticals in Q1 2021 and has held it in 16 quarters since.
  • 138 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.